Sunesis Construction Co
Construction · West Chester, Ohio
Products & Services
About Sunesis Construction Co
Sunesis Pharmaceuticals Inc (Sunesis), formerly Mosaic Pharmaceuticals, Inc., is a biopharmaceutical company. It develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company's lead product candidate Qinprezo (vosaroxin) is being developed in Phase III clinical trials for the treatment of acute myeloid leukemia (AML). It is a first-in-class anti-cancer quinolone derivative that has not been used previously for the treatment of cancer. The drug candidate is also being evaluated in Phase III clinical trials for the treatment of myelodysplastic syndromes (MDS). Its other products under pipeline include TAK-580 for solid tumors, SNS-062 for B-cell malignancies and SNS-229 for solid tumors. The company collaborates with pharmaceutical companies such as Biogen, Millennium Pharmaceuticals, Inc. and Sumitomo Dainippon to obtain licenses to develop certain products. Sunesis is headquartered in California, the US.The company reported revenues of (US Dollars) US$2.5 million for the fiscal year ended December 2016 (FY2016), a decrease of 17.2% over FY2015. The operating loss of the company was US$36.5 million in FY2016, compared to an operating loss of US$39.3 million in FY2015. The net loss of the company was US$38 million in FY2016, compared to a net loss of US$36.7 million in FY2015.The company reported revenues of US$0.7 million for the first quarter ended March 2017, a decrease of 1% over the previous quarter.
Its primary NAICS classification is 237310 (Highway, Street, and Bridge Construction). Sunesis Construction Co is one of 5,665 Construction companies listed in Ohio.
Business Contact Information
- Phone
- (513) 326-6000
- Fax
- (650) 266-3505
- Website
- www.sunesisconstruction.com
- Address
- 2610 Crescentville Rd, West Chester, Ohio, 94080, United States
Industry & Classification
- Industry
- Construction
- Sector
- Construction
- Segment
- Industrial construction
NAICS Codes
- 23Construction
- 237Heavy and Civil Engineering Construction
- 2373Highway, Street, and Bridge Construction
- 23731Highway, Street, and Bridge Construction
- 237310Highway, Street, and Bridge Construction
- 32
- 325Chemical Manufacturing
- 3254Pharmaceutical and Medicine Manufacturing
- 32541Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
SIC Codes
- 16Heavy Construction Other Than Building Construction Contractors
- 162Heavy Construction, Except Highway And Street
- 1622Other Heavy and Civil Engineering Construction
Company Details
- Employees
- 153
- Annual Revenue
- $27.4M
Sunesis Construction Co: frequently asked questions
What does Sunesis Construction Co do?
, is a biopharmaceutical company. It develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company's lead product candidate Qinprezo (vosaroxin) is being developed in Phase III clinical trials for the treatment of acute myeloid leukemia (AML).
Where is Sunesis Construction Co located?
Sunesis Construction Co is located at 2610 Crescentville Rd, West Chester, Ohio, 94080, United States.
How many employees does Sunesis Construction Co have?
Sunesis Construction Co has about 153 employees.
What is Sunesis Construction Co's annual revenue?
Sunesis Construction Co's annual revenue is estimated at $27.4M.
What industry is Sunesis Construction Co in?
Sunesis Construction Co is in the Construction / Construction industry, and its primary NAICS code is 237310 (Highway, Street, and Bridge Construction).
How can I contact Sunesis Construction Co?
Its website is www.sunesisconstruction.com and its phone number is (513) 326-6000.
What companies are similar to Sunesis Construction Co?
Other large construction companies in Ohio include M/I Homes Inc, Baker Concrete Construction Inc, Installed Building Products Inc and AFRY.
Largest construction companies in Ohio
Largest companies in Ohio
Largest construction companies
Manufacturing sales in Ohio, 2026
In Ohio, Factur's 2026 study counted 89 manufacturing quotes worth $1.2M and 31 purchase orders over 12 months: 35% of quotes became orders, against 21% nationally. See the Ohio data.
Own this business?
Keep your profile accurate — or ask us to take it down. We acknowledge requests within 7 days and resolve them within 30 days.
Prefer email? privacy@facturmfg.com
Add this badge to your website — show visitors you're listed on Factur Data.